• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性心内膜炎与心脏植入式电子设备植入术后死亡风险:一项全国性队列研究。

Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.

机构信息

Department of Cardiology, Copenhagen University Hospital Gentofte, 2900 Hellerup, Denmark.

Department of Cardiology, Copenhagen University Hospital Herlev, 2730 Herlev, Denmark.

出版信息

Europace. 2017 Jun 1;19(6):1007-1014. doi: 10.1093/europace/euw404.

DOI:10.1093/europace/euw404
PMID:28073883
Abstract

AIMS

To determine the incidence, risk factors, and mortality of infective endocarditis (IE) following implantation of a first-time, permanent, cardiac implantable electronic device (CIED).

METHODS AND RESULTS

From Danish nationwide administrative registers (beginning in 1996), we identified all de-novo permanent pacemakers (PMs) and implantable cardioverter defibrillators (ICDs) together with the occurrence of post-implantation IE-events in the period from 2000-2012. Included were 43 048 first-time PM/ICD recipients. Total follow-up time was 168 343 person-years (PYs). The incidence rate (per 1000 PYs) of IE in PM was 2.1 (95% confidence interval [CI]: 1.7-2.6) for single chamber devices and 6.2 (95% CI: 4.5-8.7) for cardiac resynchronization therapy (CRT); similarly, the rate of IE in ICD was 3.7 (95% CI: 2.9-4.7) in single chamber devices and 6.3 (95% CI: 4.4-9.0) in CRT. In multivariable analysis, increased PM complexity served as independent risk factor for IE {dual chamber PM [hazard ratio (HR) 1.39; 95% CI: 1.07-1.80] and CRT [HR: 1.84; 95% CI: 1.20-2.84]}. During follow-up, generator replacement (HR: 2.79; 95% CI: 1.87-4.17) and lead revision (HR: 4.33; 95% CI: 3.25-5.78) in PMs were associated with increased risk. Corresponding estimates in ICDs were 2.49 (95% CI: 1.28-4.86) and 6.58 (95% CI: 4.49-9.63). Risk of death after IE was significantly increased in PM and ICD with HRs of 1.56 (95% CI: 1.33-1.82) and 2.63 (95% CI: 2.00-3.48), respectively.

CONCLUSION

The risk of IE increased with increasing PM complexity. Other important risk factors were subsequent generator replacement and lead revision. IE was associated with an increased risk of mortality in the area of CIED.

摘要

目的

确定首次植入永久性心脏植入式电子设备(CIED)后感染性心内膜炎(IE)的发生率、风险因素和死亡率。

方法和结果

从丹麦全国性行政登记处(始于 1996 年)中,我们确定了 2000-2012 年期间所有新植入的永久性起搏器(PM)和植入式心脏复律除颤器(ICD)以及植入后 IE 事件的发生情况。共纳入 43048 名首次 PM/ICD 接受者。总随访时间为 168343 人年(PY)。PM 的 IE 发生率(每 1000 PY)为单腔设备 2.1(95%置信区间[CI]:1.7-2.6),心脏再同步治疗(CRT)为 6.2(95%CI:4.5-8.7);同样,ICD 中 IE 的发生率为单腔设备 3.7(95%CI:2.9-4.7),CRT 为 6.3(95%CI:4.4-9.0)。多变量分析显示,PM 复杂性增加是 IE 的独立危险因素[双腔 PM[风险比(HR)1.39;95%CI:1.07-1.80]和 CRT[HR:1.84;95%CI:1.20-2.84]。随访期间,PM 中的发电机更换(HR:2.79;95%CI:1.87-4.17)和导联修订(HR:4.33;95%CI:3.25-5.78)与风险增加相关。ICD 中的相应估计值分别为 2.49(95%CI:1.28-4.86)和 6.58(95%CI:4.49-9.63)。IE 后死亡的风险在 PM 和 ICD 中显著增加,HR 分别为 1.56(95%CI:1.33-1.82)和 2.63(95%CI:2.00-3.48)。

结论

PM 复杂性增加,IE 风险增加。其他重要的危险因素是随后的发电机更换和导联修订。IE 与 CIED 区域的死亡率增加相关。

相似文献

1
Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.感染性心内膜炎与心脏植入式电子设备植入术后死亡风险:一项全国性队列研究。
Europace. 2017 Jun 1;19(6):1007-1014. doi: 10.1093/europace/euw404.
2
Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.在一个大型全国队列中,植入起搏器、除颤器和心脏再同步治疗设备后女性与男性的生存率比较
J Am Heart Assoc. 2017 May 10;6(5):e005031. doi: 10.1161/JAHA.116.005031.
3
Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.心血管植入式电子设备植入术后感染及相关费用:一项全国性队列研究。
Europace. 2018 Dec 1;20(12):1974-1980. doi: 10.1093/europace/eux387.
4
Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.心脏植入式电子设备置换术后第一年内发生铅损伤的发生率及相关费用。
J Am Heart Assoc. 2016 Feb 12;5(2):e002813. doi: 10.1161/JAHA.115.002813.
5
Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).97750 例患者中器械相关感染的发生率:来自丹麦完整器械队列(1982-2018 年)的临床数据。
Eur Heart J. 2019 Jun 14;40(23):1862-1869. doi: 10.1093/eurheartj/ehz316.
6
Incidence, indications, risk factors, and survival of patients undergoing cardiac implantable electronic device implantation after open heart surgery.心脏直视手术后植入心脏植入式电子设备的患者的发病率、适应证、风险因素和生存率。
Europace. 2017 Aug 1;19(8):1335-1342. doi: 10.1093/europace/euw234.
7
Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.需要手术修正的植入式设备并发症的发生率、原因及其对患者预后的影响:来自意大利两个中心的大型人群调查。
Europace. 2013 Apr;15(4):531-40. doi: 10.1093/europace/eus337. Epub 2013 Feb 13.
8
Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.植入式心脏复律除颤器与永久性起搏器的装置感染:一项系统评价和荟萃分析。
J Cardiovasc Electrophysiol. 2019 Jul;30(7):1053-1065. doi: 10.1111/jce.13932. Epub 2019 Apr 17.
9
Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement.心脏植入式电子设备与主动脉瓣置换术患者感染性心内膜炎的相关风险。
Europace. 2018 Oct 1;20(10):e164-e170. doi: 10.1093/europace/eux360.
10
Venous thromboembolism in patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者的静脉血栓栓塞症。
Europace. 2017 Jun 1;19(6):991-1001. doi: 10.1093/europace/euw124.

引用本文的文献

1
Home-Based Self-Management After Permanent Pacemaker Implantation: What Should Patients Know.永久性起搏器植入术后的居家自我管理:患者应该了解什么。
Patient Prefer Adherence. 2025 Sep 8;19:2771-2786. doi: 10.2147/PPA.S535177. eCollection 2025.
2
Predictors of Mortality in Patients with Cardiac Device-Related Infective Endocarditis.心脏装置相关感染性心内膜炎患者死亡的预测因素
Trop Med Infect Dis. 2024 Aug 24;9(9):193. doi: 10.3390/tropicalmed9090193.
3
Cardiovascular Implantable Electronic Device Infections: A Contemporary Review.
心血管植入式电子设备感染:当代综述。
Infect Dis Clin North Am. 2024 Dec;38(4):673-691. doi: 10.1016/j.idc.2024.07.004. Epub 2024 Sep 10.
4
Paradigm Shifts in Cardiac Pacing: Where Have We Been and What Lies Ahead?心脏起搏的范式转变:我们何去何从,未来又将如何?
J Clin Med. 2023 Apr 18;12(8):2938. doi: 10.3390/jcm12082938.
5
Brazilian Guidelines for Cardiac Implantable Electronic Devices - 2023.《巴西心脏植入式电子设备指南 - 2023》
Arq Bras Cardiol. 2023 Jan 23;120(1):e20220892. doi: 10.36660/abc.20220892.
6
Native valve, prosthetic valve, and cardiac device-related infective endocarditis: A review and update on current innovative diagnostic and therapeutic strategies.自体瓣膜、人工瓣膜及心脏装置相关感染性心内膜炎:当前创新诊断与治疗策略的综述与更新
Front Cell Dev Biol. 2022 Oct 3;10:995508. doi: 10.3389/fcell.2022.995508. eCollection 2022.
7
Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study.根据感染性心内膜炎的微生物学病因的时间变化、患者特征和死亡率:一项全国性研究。
J Am Heart Assoc. 2022 Aug 16;11(16):e025801. doi: 10.1161/JAHA.122.025801. Epub 2022 Aug 10.
8
Follow the Lead: The Challenges of Cardiogenic Shock in Device-Related Infective Endocarditis.紧跟前沿:与装置相关的感染性心内膜炎中心源性休克的挑战。
JACC Case Rep. 2021 Aug 4;3(9):1163-1169. doi: 10.1016/j.jaccas.2021.05.012.
9
Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project-a position paper.两种平行试验中应用个体化植入标准的伦理学问题:植入式心脏复律除颤器一级预防的 PROFID 项目——立场文件。
Open Heart. 2021 Jul;8(2). doi: 10.1136/openhrt-2021-001686.
10
Device infections related to cardiac resynchronization therapy in clinical practice-An analysis of its prevalence, risk factors and routine surveillance at a single center university hospital.临床中心脏再同步治疗相关器械感染:单中心大学医院的流行率、危险因素和常规监测分析。
Clin Cardiol. 2021 Jun;44(6):739-747. doi: 10.1002/clc.23620. Epub 2021 May 25.